Chin Athena, Adams Robert J, Gill Tiffany K, Hill Catherine L
Rheumatology Unit, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia.
Flinders Health and Medical Research Institute - Sleep Health, Flinders University, Bedford Park, South Australia, Australia.
Open Access Rheumatol. 2024 Jan 13;16:1-7. doi: 10.2147/OARRR.S435692. eCollection 2024.
The prevalence of gout has increased in the Western societies due to ageing and increasing BMI. Recently, lifestyle and dietary factors have been linked in epidemiological studies with an alteration of the risk of gout; however, there remains a lack of data on patient knowledge of these factors. The purpose of this survey-based study was to determine the knowledge of gout and its treatment both in the community and specialist care settings.
Participants were recruited from a hospital rheumatology outpatient department, consumer organization and a random sample of participants from a population-based cohort who had self-reported gout in South Australia. Participants completed a survey regarding basic demographics, the Single Item Literacy Screener, use of medication and diet for treatment of their gout and knowledge of gout.
Seventy-four people were recruited (87% male) with a mean age of 66 years (range 35-88). The mean duration of gout was 16.6 years (range 0-60). On screening with SILS, 19.0% were identified as having limited reading ability. Most gout was managed by the family practitioner (81.1%) and/or rheumatologist (18.9%). In regard to current gout medications, 52.7% were taking allopurinol, 17.6% colchicine, 9.5% non-steroidal anti-inflammatory drugs, 6.8% prednisolone and 5.4% herbal preparations. For further information regarding gout, participants would most commonly approach their general practitioner (85.1%). Most participants correctly identified certain triggers to gout attacks and almost half of participants (41.9%) reported that they had altered their diet due to gout. Conversely, participants often incorrectly identified common risk or protective factors for gout.
Gout remains a common, yet undertreated, chronic condition. Our study highlights a lack of knowledge amongst patients of risk and protective factors in relation to gout. The increasing prevalence of gout within the population indicates a need to improve education and understanding among those with the condition.
由于老龄化和体重指数(BMI)的增加,痛风在西方社会的患病率有所上升。最近,生活方式和饮食因素在流行病学研究中与痛风风险的改变有关;然而,关于患者对这些因素的了解的数据仍然缺乏。这项基于调查的研究的目的是确定社区和专科护理环境中对痛风及其治疗的了解情况。
参与者从医院风湿病门诊、消费者组织以及南澳大利亚一个基于人群队列中自我报告患有痛风的参与者随机样本中招募。参与者完成了一项关于基本人口统计学、单项识字筛查、用于治疗痛风的药物和饮食以及痛风知识的调查。
招募了74人(87%为男性),平均年龄66岁(范围35 - 88岁)。痛风的平均病程为16.6年(范围0 - 60年)。通过SILS筛查,19.0%被确定为阅读能力有限。大多数痛风患者由家庭医生(81.1%)和/或风湿病学家(18.9%)管理。关于当前的痛风药物,52.7%正在服用别嘌醇,17.6%服用秋水仙碱,9.5%服用非甾体抗炎药,6.8%服用泼尼松龙,5.4%服用草药制剂。对于有关痛风的进一步信息,参与者最常咨询他们的全科医生(85.1%)。大多数参与者正确识别了某些痛风发作的诱因,近一半的参与者(41.9%)报告说他们因痛风而改变了饮食。相反,参与者经常错误地识别痛风的常见风险或保护因素。
痛风仍然是一种常见但治疗不足的慢性病。我们的研究突出了患者对痛风相关风险和保护因素缺乏了解。人群中痛风患病率的上升表明需要改善患者对该疾病的教育和理解。